ARK Investment Management’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-77
Closed -$7.86K 188
2025
Q4
$7.86K Sell
77
-2,186,091
-100% -$176M ﹤0.01% 196
2025
Q3
$120M Buy
2,186,168
+2,186,132
+6,072,589% +$109M 0.71% 41
2025
Q2
$1.91K Hold
36
﹤0.01% 189
2025
Q1
$1.56K Sell
36
-80,023
-100% -$4.05M ﹤0.01% 191
2024
Q4
$4.5M Sell
80,059
-147,385
-65% -$9.17M 0.04% 111
2024
Q3
$15.5M Sell
227,444
-117,043
-34% -$6.61M 0.14% 73
2024
Q2
$14.6M Sell
344,487
-2,923,161
-89% -$161M 0.13% 82
2024
Q1
$226M Sell
3,267,648
-2,765,245
-46% -$175M 1.56% 20
2023
Q4
$446M Sell
6,032,893
-248,038
-4% -$16.3M 2.64% 13
2023
Q3
$428M Sell
6,280,931
-874,167
-12% -$74.2M 3.28% 8
2023
Q2
$672M Sell
7,155,098
-4,224,089
-37% -$330M 4.45% 7
2023
Q1
$772M Sell
11,379,187
-4,661,303
-29% -$300M 5.3% 6
2022
Q4
$794M Sell
16,040,490
-1,521,212
-9% -$62.2M 6.88% 1
2022
Q3
$571M Buy
17,561,702
+2,589,937
+17% +$107M 3.98% 5
2022
Q2
$746M Buy
14,971,765
+647,803
+5% +$34.6M 4.41% 5
2022
Q1
$1B Buy
14,323,962
+827,948
+6% +$60.5M 4.18% 6
2021
Q4
$1.05B Buy
13,496,014
+1,767,385
+15% +$156M 3.18% 9
2021
Q3
$1.12B Buy
11,728,629
+1,001,839
+9% +$106M 2.69% 10
2021
Q2
$1.33B Buy
10,726,790
+1,578,155
+17% +$188M 2.48% 9
2021
Q1
$1.21B Buy
9,148,635
+3,836,169
+72% +$525M 2.39% 6
2020
Q4
$704M Buy
5,312,466
+4,783,270
+904% +$578M 1.87% 14
2020
Q3
$54M Buy
+529,196
New +$45.7M 0.32% 55

Other funds holding EXAS

ARK Investment Management's EXAS Position: Q1 2026 in Review

ARK Investment Management sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 77 shares — an estimated $7.86K sold.

ARK Investment Management first reported a position in EXAS in Q3 2020 and held it in 22 quarters. The position peaked at $1.33B in Q2 2021. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • ARK Investment Management reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • ARK Investment Management sold 77 Exact Sciences shares in Q1 2026, an estimated $7.86K.
  • ARK Investment Management first reported a position in Exact Sciences in Q3 2020 and held it in 22 quarters.
  • ARK Investment Management's Exact Sciences position peaked at $1.33B in Q2 2021.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on ARK Investment Management's 13F filing for Q1 2026, filed 12 May 2026.